Literature DB >> 1001617

The adjuvant properties of liposomes.

T D Heath, D C Edwards, B E Ryman.   

Abstract

Mesh:

Substances:

Year:  1976        PMID: 1001617     DOI: 10.1042/bst0040129

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  15 in total

Review 1.  Immunopotentiation and delivery systems for antigens for single-step immunization: recent trends and progress.

Authors:  M Z Khan; J P Opdebeeck; I G Tucker
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

2.  Comparison between multilamellar and unilamellar liposomes in enhancing antibody formation.

Authors:  P N Shek; B Y Yung; N Z Stanacev
Journal:  Immunology       Date:  1983-05       Impact factor: 7.397

3.  Immune response mediated by liposome-associated protein antigens. II. Comparison of the effectiveness of vesicle-entrapped and surface-associated antigen in immunopotentiation.

Authors:  P N Shek; B H Sabiston
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

4.  Immunoadjuvant activity of synthetic N-acetyl muramyl dipeptide.

Authors:  K Masek; M Zaoral; J Jezek; R Straka
Journal:  Experientia       Date:  1978-10-15

5.  Alterations of the carrier-mediated transport of an anionic solute, methotrexate, by charged liposomes in Ehrlich ascites tumor cells.

Authors:  D W Fry; J C White; I D Goldman
Journal:  J Membr Biol       Date:  1979-10-15       Impact factor: 1.843

6.  Liposomal enhancement of the immunogenicity of adenovirus type 5 hexon and fiber vaccines.

Authors:  W J Kramp; H R Six; S Drake; J A Kasel
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

7.  Enhancement of immunogenicity of tumour virus antigen by liposomes: the effect of lipid composition.

Authors:  O Bakouche; D Gerlier
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

8.  Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.

Authors:  S M Sivakumar; Mohammed M Safhi; M Kannadasan; N Sukumaran
Journal:  Saudi Pharm J       Date:  2011-06-25       Impact factor: 4.330

9.  Immune response mediated by liposome-associated protein antigens. IV. Modulation of antibody formation by vesicle-encapsulated methotrexate.

Authors:  P N Shek; N G Lopez; T D Heath
Journal:  Immunology       Date:  1986-01       Impact factor: 7.397

10.  Presentation of an MuLV-related tumour antigen in liposomes as a potent tertiary immunogen after adoptive transfer.

Authors:  O Bakouche; D Gerlier
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.